Dagrocorat hydrochloride
Modify Date: 2024-01-08 02:10:20
Dagrocorat hydrochloride structure
|
Common Name | Dagrocorat hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1044535-61-6 | Molecular Weight | 531.01 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H30ClF3N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Dagrocorat hydrochlorideDagrocorat (PF-00251802) hydrochloride is an orally active and selective high-affinity partial agonist of the glucocorticoid receptor. Dagrocorat hydrochloride is also a time-dependent reversible inhibitor of CYP3A (IC50=1.3 μM in human liver microsomes) and CYP2D6 (Ki=0.57 μM in human liver microsomes). Dagrocorat hydrochloride can be used for the research of rheumatoid arthritis[1]. |
| Name | (4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide,hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Dagrocorat (PF-00251802) hydrochloride is an orally active and selective high-affinity partial agonist of the glucocorticoid receptor. Dagrocorat hydrochloride is also a time-dependent reversible inhibitor of CYP3A (IC50=1.3 μM in human liver microsomes) and CYP2D6 (Ki=0.57 μM in human liver microsomes). Dagrocorat hydrochloride can be used for the research of rheumatoid arthritis[1]. |
|---|---|
| Related Catalog | |
| Target |
CYP3A CYP2D6 |
| In Vitro | Dagrocorat hydrochloride is metabolized by cytochrome P450 (CYP)3A to an N-oxide metabolite. Dagrocorat hydrochloride is a reversible inhibitor of several CYPs, such as CYP3A and CYP2D6[1]. |
| References |
| Molecular Formula | C29H30ClF3N2O2 |
|---|---|
| Molecular Weight | 531.01 |
| Exact Mass | 530.19500 |
| PSA | 62.22000 |
| LogP | 7.03750 |
| unii-vl45kv749o |